2.49CNY
4.06 BCNY
75.17 BCNY
534.16 M
About GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Sector
CEO
Hong Li
Headquarters
Guangzhou
Website
Employees (FY)
28.05 K
Founded
1997
ISIN
CNE000001733
FIGI
BBG000FM3Z94
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 600332 is 31.54 CNY — it has increased by 2.74% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stocks are traded under the ticker 600332.
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
600332 stock is 3.57% volatile and has beta coefficient of 0.72. Check out the list of the most volatile stocks — is GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED there?
One year price forecast for GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED has a max estimate of 36.10 CNY and a min estimate of 23.00 CNY.
600332 earnings for the last quarter are 0.60 CNY per share, whereas the estimation was 0.55 CNY resulting in a 9.64% surprise. The estimated earnings for the next quarter are 0.34 CNY per share. See more details about GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED earnings.
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED revenue for the last quarter amounts to 17.59 B CNY despite the estimated figure of 21.19 B CNY. In the next quarter revenue is expected to reach 13.38 B CNY.
Yes, you can track GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED financials in yearly and quarterly reports right on TradingView.
600332 stock has risen by 9.55% compared to the previous week, the month change is a 8.20% rise, over the last year GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED has showed a 8.69% decrease.
600332 net income for the last quarter is 264.43 M CNY, while the quarter before that showed 980.00 M CNY of net income which accounts for −73.02% change. Track more GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED financial stats to get the full picture.
Today GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED has the market capitalization of 51.28 B, it has decreased by 1.26% over the last week.
Yes, 600332 dividends are paid annually. The last dividend per share was 0.73 CNY. As of today, Dividend Yield (TTM)% is 2.32%. Tracking GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED dividends might help you take more informed decisions.
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED dividend yield was 2.37% in 2023, and payout ratio reached 27.17%. The year before the numbers were 2.35% and 28.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 600332 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 28.05 K employees. See our rating of the largest employees — is GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stock shows the strong buy signal. See more of GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED future price: according to them, 600332 price has a max estimate of 36.10 CNY and a min estimate of 23.00 CNY. Read a more detailed GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED forecast: see what analysts think of GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED EBITDA is 5.43 B CNY, and current EBITDA margin is 7.23%. See more stats in GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED financial statements.